Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
Background: Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among prostate cancer patients. Here, our aim was to ascertain the immune regulatory mechanisms involved in CRPC development and identify potential immunotherapies against CRPC. Methods: A CRPC model was...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fd436a2d1e8b4d2a9fc27ac955ff189d |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|